title: A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.
authors.affiliation: Analytical Research Department, Abbott Laboratories, North Chicago, IL 60064.
authors.forename: D K
authors.initials: DK
authors.lastname: Morgan
authors.forename: D M
authors.initials: DM
authors.lastname: Brown
authors.forename: T D
authors.initials: TD
authors.lastname: Rotsch
authors.forename: A C
authors.initials: AC
authors.lastname: Plasz
mesh_terms: D002214:Capsules; D002851:Chromatography, High Pressure Liquid; D017291:Clarithromycin; D004355:Drug Stability; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000032:analysis; D065347:Hypromellose Derivatives; D007267:Injections; D008747:Methylcellulose / Q000031:analogs & derivatives; D013056:Spectrophotometry, Ultraviolet; D013535:Suspensions; D013607:Tablets
chemical_list: D002214:Capsules; D013535:Suspensions; D013607:Tablets; D065347:Hypromellose Derivatives; D004917:Erythromycin; D008747:Methylcellulose; D017291:Clarithromycin